On December 23, 2011, the U.S. Centers for Disease Control and Prevention released new recommendations on the use of hepatitis B vaccine for adults with diabetes mellitus.  All previously unvaccinated adults aged 19 through 59 years with diabetes mellitus (type 1 and type 2) should be vaccinated against hepatitis B as soon as possible after a diagnosis of diabetes is made.  Unvaccinated adults aged ≥60 years with diabetes may be vaccinated at the discretion of the treating clinician after assessing their risk and the likelihood of an adequate immune response to vaccination.

The Hepatitis Vaccines Work Group of the Advisory Committee on Immunization Practices (ACIP) evaluated the risk for HBV infection among all adults with diagnosed diabetes. The work group presented its findings at the October 25, 2011 meeting of the ACIP. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology,  the recommendation for younger adults received an A grade. The recommendation for adults ≥60 received a B grade.

You can read more about the recommendations at:

https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a4.htm?s_cid=mm6050a4_e